Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Study Finds Financial Incentives for Low-Risk Clinical Trials are Ethical
Scientific Advances

Study Finds Financial Incentives for Low-Risk Clinical Trials are Ethical

By Melissa RohmanOct 25, 2021
Share
Facebook Twitter Email
Brian Hitsman, PhD, associate professor of Preventive Medicine in the Division of Behavioral Medicine, of Medical Social Sciences and of Psychiatry and Behavioral Sciences, was a co-author of the study published in JAMA Internal Medicine.

Use of financial incentives in two low-risk randomized clinical trials did not present ethical issues, and in one of the trials, the incentives increased study participation, according to findings published in JAMA Internal Medicine.

The results may help address the long-standing problem of low or insufficient enrollment in clinical trials in many areas of medicine, said Brian Hitsman, PhD, associate professor of Preventive Medicine in the Division of Behavioral Medicine, and a co-author of the study.

“Hopefully, our results will encourage people to open up to the idea of increasing enrollment in lower risk clinical trials through financial incentives to participants,” said Hitsman, who is also an associate professor of Medical Social Sciences and of Psychiatry and Behavioral Sciences.

One of the greatest barriers to accurate and efficient randomized clinical trials is the difficulty in enrolling participants. Historically, investigators have sought to increase study enrollment through several strategies, including offering financial incentives to study participants. However, whether this practice actually increases participation remained understudied.

Additionally, the ethics of the practice have long been an unanswered question, according to the authors. Two of the most common concerns among investigators with incentivizing research participation is that incentives may represent undue inducements — dismissing or downplaying the risks associated with research participation, thereby interfering with full informed consent — or unjust inducements — encouraging enrollment among people with lower income levels who otherwise would not have participated in the study.

For the current study, a total of 1,296 eligible participants were enrolled in two incentivized randomized clinical trials — one comparing smoking cessation interventions and one evaluating an ambulation (walking) intervention. Hitsman was principal investigator for the smoking trial’s clinical site at Northwestern.

Participants in the smoking trial were 50 percent women; an average age of 50 years; and 60 percent identified as Black or African American, 32.7 percent identified as white and 3.7 percent identified as multiracial. Participants in the ambulation trial were 57 percent women; an average age of 47 years; and 35 percent identified as Black or African American, 52 percent identified as white and less than one percent identified as multiracial.

Participants were then randomly assigned to receive financial incentives of either $0, $200 or $500 for participating in the smoking trial and $0, $100 or $300 for the walking trial.

The conclusion of both trials revealed that while financial incentives increased enrollment in the smoking cessation trial, they did not increase enrollment the walking trial. Noninferiority tests performed by investigators also found that incentives did not disproportionately motivate participants who reported lower income levels to enroll (unjust inducement) or a lower perceived risk of participating in the trials (undo inducement).

“One potential explanation for the different results is that the ambulation trial offered a lower risk intervention than the smoking cessation trial,” said Hitsman, who is also a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

The results suggest that while offering financial incentives for study participation are not unethical, the effectiveness and ethicality of financial incentives offered for high-risk clinical trials warrants further investigation, according to the authors.

“Although the two ‘parent’ clinical trials differed in terms of true risk, a limitation of the smoking cessation study is that both trials were testing lower-risk interventions. It is possible that the effect of enrollment incentives on candidates considering higher risk medical interventions, such as cancer treatment, may be different, so this needs to be studied next,” Hitsman said.

This work was supported by the National Cancer Institute grants R01CA197332 and R01CA184211.

Medical Social Sciences Research
Share. Facebook Twitter Email

Related Posts

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

Comments are closed.

Latest News

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.